This inventor holds 0 USPTO granted patents, plus 7 CIPO patents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Title: Indrawan James Mcalpine: Innovator in Pharmaceutical Compounds
Introduction
Indrawan James Mcalpine is a notable inventor based in the United States. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that may aid in the treatment of various diseases.
Latest Patents
Mcalpine holds patents for innovative compounds, including "Cyclopentane-Based Modulators Of Sting" and "Novel 3-Indol Substituted Derivatives." The first patent focuses on compounds that act as activators of STING (Stimulator of Interferon Genes), which could be beneficial in treating abnormal cell growth, such as cancer, in mammals. The second patent involves compounds that serve as TDO2 inhibitors, with potential applications in treating cancer, neurodegenerative disorders, chronic viral infections, depression, and obesity.
Career Highlights
Throughout his career, Mcalpine has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Iteos Therapeutics. His work has contributed to advancements in medical treatments and therapies.
Collaborations
Mcalpine has collaborated with notable professionals in his field, including Sacha Ninkovic and Stefano Crosignani. These partnerships have likely enhanced the scope and impact of his research.
Conclusion
Indrawan James Mcalpine is a distinguished inventor whose work in pharmaceutical compounds has the potential to make a significant impact on healthcare. His innovative approaches to treating complex diseases highlight the importance of research and development in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile